e-learning
resources
Virtual 2020
Wednesday, 09.09.2020
Advances in pharmacological treatment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study
L. Karimi (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), L. Lahousse (Ghent, Belgium), P. De Nocker (Ghent, Belgium), B. Stricker (Rotterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands)
Source:
Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Session:
Advances in pharmacological treatment of COPD
Session type:
Oral Presentation
Number:
5233
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Karimi (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), L. Lahousse (Ghent, Belgium), P. De Nocker (Ghent, Belgium), B. Stricker (Rotterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands). The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study. 5233
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014
Prevalence and incidence of COPD: The Rotterdam study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study
Source: International Congress 2019 – Genes and environment
Year: 2019
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
The lifetime risk of developing COPD. The Rotterdam study
Source: Annual Congress 2008 - Environmental risk factors for respiratory symptoms and COPD
Year: 2008
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx)
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Factors associated with COPD exacerbation frequency in a UK primary care cohort
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Effects of ambient temperature on COPD symptoms and exacerbations in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) cohort
Source: Virtual Congress 2021 – Environment and respiratory health
Year: 2021
The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
The Rotterdam study: why fall in COPD?
Source: Eur Respir J 2015; 46: 1529-1530
Year: 2015
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The Rotterdam study: why fall in COPD?
Source: Eur Respir J 2015; 46: 1530-1531
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept